13
Views
1
CrossRef citations to date
0
Altmetric
ARTICLES

Arylesterase and Paraoxonase-1 Activities in Female Patients with Temporomandibular Disorders

, DDS, PhD, , DDS, PhD, , PhD & , PhD
Pages 239-245 | Received 05 Apr 2007, Accepted 16 Jan 2008, Published online: 09 Sep 2009
 

Abstract

Objective: The aim of this study was to assess a possible relationship between temporomandibular disorders [TMD] and serum levels of sulfhydryl [SH] groups and ceruloplasmin [CP], paraoxonase-1 [PON1], and arylesterase [ARE] activities.

Method: This study included patients with TMD and healthy normal controls [HNC]. After clinical and radiographic examinations, the patient group was given a visual analog scale to determine severity of pain. Serum samples of the subjects were obtained to calculate certain antioxidant components. The CP, PON1, and ARE activities and serum levels of SH groups were measured.

Results: There were 31 patients with TMD and 35 HNC. Serum levels of SH and ARE activity of the TMD group were significantly lower than those of the HNC group [P < 0.05]. The difference between CP and PON1 activity of the TMD and HNC groups were not statistically significant [P > 0.05]. No association was found between antioxidant levels and severity of pain and the type of the TMD.

Conclusions: Antioxidant components may be associated with TMD, implying possible systemic inflammatory and oxidative aspect of TMD.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.